Nusrat Ahmad Chaudhary, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 |
Adam Rea Kuykendal, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 |
Mr. Lance King Lassiter, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1700 Matthews Township Pkwy, Matthews, NC 28105 Phone: 704-841-8151 Fax: 704-841-9228 |
Neelam Vijay Desai, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1100 Healing Way, Ste 31, Matthews, NC 28104 Phone: 980-442-0600 |
Dr. Richard Stevens Foulke, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3036 Senna Drive, Matthews, NC 28105 Phone: 704-841-8151 Fax: 704-841-9228 |
News Archive
Berlin is the host city of the 11th IAS Conference on HIV Science, the International AIDS Society announced today. The city hosted the 9th International AIDS Conference in 1993, but this is the first time that it will host the IAS Conference on HIV Science.
The Renfrew Center, the country's leading authority on eating disorder treatment and research, recently announced the expansion of its services into Central America through a partnership with the Guatemala-based AKASA treatment center. The first center in Central America exclusively dedicated to the treatment of women with eating disorders, AKASA now operates as an independent affiliate of The Renfrew Center.
Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association's Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.
Two eye surgeons have written a first-of-its-kind book to save the sight of millions of patients around the world by making eye injections safe and comfortable.
PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
› Verified 5 days ago